Published in Healthcare Finance, Tax and Law Weekly, August 23rd, 2006
For the first fiscal quarter ended June 30, 2006, Abaxis reported revenues of $20.4 million, as compared with revenues of $14.3 million for the comparable period last year, an increase of 43%. Instrument revenue, reagent disc and hematology reagent revenue increased by $5.5 million or 41% over the same period last year. The company reported net income attributable to common shareholders of $2.4 million, compared to $1.0 million for the same period last year.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.